Gefitinib Gefticip 250 mg
$111.00 – $315.00
Description
Gefitinib is a medication primarily used in the treatment of non-small cell lung cancer (NSCLC) that harbors specific genetic mutations known as epidermal growth factor receptor (EGFR) mutations. It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking the activity of specific proteins involved in cancer cell growth and spread. Gefitinib is specifically indicated for patients with locally advanced or metastatic NSCLC whose tumors have EGFR mutations. It is typically taken orally in tablet form.
| Active Ingredient (Generic Name): | Gefitinib |
| Manufacturer: |
Cipla Limited
|
| Packaging: | 30 tablets in 1 bottle |
| Strength: | 250 mg |
| Delivery Time: | 6 To 15 days |
| SKU: | Gefitinib Gefticip 250 mg |
Additional information
| Quantity Value | 30 Tablet/s, 60 Tablet/s, 90 Tablet/s |
|---|
Be the first to review “Gefitinib Gefticip 250 mg”
You must be logged in to post a review.
Related products
-
Lenalidomide 25 mg
$300.00 – $878.00 Select options This product has multiple variants. The options may be chosen on the product page -
Posaconazole 100 mg
$110.00 – $323.00 Select options This product has multiple variants. The options may be chosen on the product page -
Imatinib 400 mg
$75.00 – $207.00 Select options This product has multiple variants. The options may be chosen on the product page -
Afatinib 20 mg
$98.00 – $278.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.